デフォルト表紙
市場調査レポート
商品コード
1536158

伝染性腸炎治療の世界市場

Infectious Enteritis Treatment

出版日
ページ情報
英文 276 Pages
納期
即日から翌営業日
適宜更新あり
伝染性腸炎治療の世界市場
出版日: 2024年08月16日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 276 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

伝染性腸炎治療の世界市場は2030年までに6億2,280万米ドルに達する見込み

2023年に4億4,000万米ドルと推定される伝染性腸炎治療の世界市場は、2023年から2030年にかけてCAGR 5.1%で成長し、2030年には6億2,280万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである抗生物質は、CAGR 5.7%を記録し、分析期間終了時には3億5,320万米ドルに達すると予測されます。抗ウイルス剤セグメントの成長率は、分析期間中CAGR 4.4%と推定されます。

米国市場は1億1,990万米ドルと推定、中国はCAGR 8.4%で成長予測

米国の伝染性腸炎治療市場は、2023年に1億1,990万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億3,020万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.0％と5.3％と予測されています。欧州では、ドイツがCAGR 3.1%で成長すると予測されています。

世界の伝染性腸炎治療市場- 主要動向と促進要因まとめ

感染性腸炎は、細菌、ウイルス、寄生虫を含むさまざまな病原体によって引き起こされる腸の炎症です。一般的な原因としては、ロタウイルス、ノロウイルス、大腸菌、サルモネラ菌などが挙げられ、下痢、腹痛、嘔吐、発熱などの症状を引き起こします。感染経路は通常、汚染された食物や水の摂取、または感染者との直接接触です。感染性腸炎の治療は、症状の重症度や感染した病原体によって異なります。ウイルス感染症の場合、抗生物質は無効であるため、一般的には水分補給と電解質バランスに重点を置いた支持療法が行われます。細菌感染や寄生虫感染の場合は、便検査やその他の診断方法によって同定された病原体に基づいて、特定の抗菌薬が処方されます。どのような場合でも、水分補給を維持することが重要であり、特に幼児や高齢者のような脆弱な集団にとっては、重篤な脱水のリスクが高くなります。

感染性腸炎を管理するアプローチは、診断ツールや治療戦略の進歩とともに進化してきました。迅速診断検査がますます利用できるようになり、原因菌の迅速な特定と適切な管理の早期開始が可能になった。これは、地域環境や集団発生時の感染拡大を防ぐ上で特に重要です。さらに、腸炎の治療と予防のためのガイドラインの策定と普及にも大きな進展があり、ロタウイルスに対するワクチンなど、利用可能な場合にはその使用を推奨しています。水質の改善、手指衛生の促進、安全な食品取扱方法の教育に重点を置いた公衆衛生上の取り組みも、世界の感染性腸炎の発生率減少に重要な役割を果たしています。

伝染性腸炎治療市場の成長は、世界の人口増加、疾患に対する認識の高まり、治療・診断技術の進歩など、いくつかの要因によってもたらされます。世界人口の増加に伴い、特に発展途上地域では、衛生環境、清潔な水へのアクセス、公衆衛生インフラの課題により、腸管感染症の負担が増加しています。このため、予防対策と効果的な治療の両方に対する需要が高まっています。ゲノムおよび分子診断技術の進歩は、より迅速かつ正確な病原体の特定を可能にし、ひいては標的療法の開発を支援します。さらに、ワクチンや公衆衛生教育を通じた疾病予防の重要性に対する意識の高まりも、市場の成長に寄与しています。消費者の行動は、水分補給液やプロバイオティクスなど、より迅速で効果的な治療を求める方向にシフトしており、これらは腸の健康をサポートする利点が認められて人気を集めています。こうした動きは、感染性腸炎の治療において革新的で効果的なソリューションに対する需要が堅調に推移していることを示しています。

調査対象企業の例（全86件）

  • AdvaCare Pharma
  • Astellas Pharma, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Centurion Healthcare Private Limited
  • Merck & Co., Inc.
  • Tokushukai Medical Group

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26659

Global Infectious Enteritis Treatment Market to Reach US$622.8 Million by 2030

The global market for Infectious Enteritis Treatment estimated at US$440.0 Million in the year 2023, is expected to reach US$622.8 Million by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$353.2 Million by the end of the analysis period. Growth in the Antiviral Drugs segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$119.9 Million While China is Forecast to Grow at 8.4% CAGR

The Infectious Enteritis Treatment market in the U.S. is estimated at US$119.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$130.2 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Infectious Enteritis Treatment Market - Key Trends and Drivers Summarized

Infectious enteritis is an inflammation of the intestines caused by a variety of pathogens, including bacteria, viruses, and parasites. Common culprits include rotavirus, norovirus, Escherichia coli, and Salmonella, which can lead to symptoms such as diarrhea, abdominal pain, vomiting, and fever. The disease transmission typically occurs through consumption of contaminated food or water, or direct contact with infected individuals. Treatment for infectious enteritis depends on the severity of the symptoms and the specific pathogen involved. For viral infections, management is generally supportive, focusing on hydration and electrolyte balance, as antibiotics are not effective. For bacterial or parasitic infections, specific antimicrobials are prescribed based on the organism identified through stool tests or other diagnostic methods. In all cases, maintaining hydration is critical, especially for vulnerable populations such as young children and the elderly, who are at higher risk of severe dehydration.

The approach to managing infectious enteritis has evolved with advances in diagnostic tools and treatment strategies. Rapid diagnostic tests have become increasingly available, enabling quicker identification of the causative agent and appropriate management to be initiated sooner. This is particularly important in preventing the spread of infections in community settings and during outbreaks. Furthermore, there has been significant progress in developing and disseminating guidelines for the treatment and prevention of enteritis, including recommendations for the use of vaccines where available, such as those against rotavirus. Public health initiatives focusing on improving water quality, promoting hand hygiene, and educating about safe food handling practices also play a crucial role in reducing the incidence of infectious enteritis globally.

The growth in the infectious enteritis treatment market is driven by several factors, including global population growth, increased awareness of the disease, and advancements in medical treatments and diagnostic technologies. As the global population increases, particularly in developing regions, there is a higher burden of enteric infections due to challenges in sanitation, clean water access, and public health infrastructure. This drives demand for both preventive measures and effective treatments. Advancements in genomic and molecular diagnostic techniques allow for more rapid and accurate pathogen identification, which in turn supports the development of targeted therapies. Additionally, the rising awareness of the importance of disease prevention through vaccines and public health education contributes to market growth. Consumer behavior has shifted towards seeking quicker, more effective treatments, including rehydration solutions and probiotics, which are gaining popularity for their perceived benefits in supporting gut health. These dynamics indicate a robust ongoing demand for innovative and effective solutions in the treatment of infectious enteritis.

Select Competitors (Total 86 Featured) -

  • AdvaCare Pharma
  • Astellas Pharma, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Centurion Healthcare Private Limited
  • Merck & Co., Inc.
  • Tokushukai Medical Group

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Infectious Enteritis Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidences of Infectious Enteritis Drive Urgency for Effective Treatment Solutions
    • Advances in Microbiome Research Strengthen Business Case for Targeted Enteritis Therapies
    • Growth in Travel and Exposure to Novel Pathogens Sets the Stage for Broader Enteritis Treatment Needs
    • Development of Rapid Diagnostic Tests for Enteric Pathogens Enhances Treatment Efficiency
    • Growing Focus on Pediatric and Elderly Populations Drives Specialized Treatment Approaches
    • Consumer Preferences for Alternative and Herbal Medicines Impact Traditional Treatment Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Infectious Enteritis Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Infectious Enteritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Antiviral Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Injectables Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Injectables Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Injectables Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • JAPAN
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • CHINA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • EUROPE
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Infectious Enteritis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • FRANCE
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • GERMANY
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Infectious Enteritis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • INDIA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Infectious Enteritis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Infectious Enteritis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • AFRICA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030

IV. COMPETITION